These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 25561817

  • 1. Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure.
    Li HM, Ye ZH, Zhang J, Gao X, Chen YM, Yao X, Gu JX, Zhan L, Ji Y, Xu JL, Zeng YH, Yang F, Xiao L, Sheng GG, Xin W, Long Q, Zhu QJ, Shi ZH, Ruan LG, Yang JY, Li CC, Wu HB, Chen SD, Luo XL.
    World J Gastroenterol; 2014 Dec 28; 20(48):18458-65. PubMed ID: 25561817
    [Abstract] [Full Text] [Related]

  • 2. [A prospective cohort study on the influence of high doses of herbs for clearing heat and resolving stasis on survival rates in patients with hepatitis B-related acute-on-chronic liver failure].
    Hu XY, Zhang Y, Chen G, Zhong S, Fan XJ.
    Zhong Xi Yi Jie He Xue Bao; 2012 Feb 28; 10(2):176-85. PubMed ID: 22313885
    [Abstract] [Full Text] [Related]

  • 3. Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.
    Guo YM, Li FY, Gong M, Zhang L, Wang JB, Xiao XH, Li J, Zhao YL, Wang LF, Zhang XF.
    Chin J Integr Med; 2016 Aug 28; 22(8):573-80. PubMed ID: 27220737
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of integrative medical program based on blood cooling and detoxification recipe in treating patients with hepatitis B virus related acute-on-chronic liver failure: a randomized controlled clinical study].
    Liu HM, Wang XB, Hou YX, Gao FY, Sun FX, Jiang YY, Yang ZY, Du HB, Wang XJ, Zhou GQ, Yang YY, Wang RB.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Apr 28; 34(4):412-7. PubMed ID: 24812894
    [Abstract] [Full Text] [Related]

  • 5. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
    Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, Wei LB, Cao SL, Yang NZ, Ma HZ, Gao J, Li P, Tao XJ, Yuan FH, Li J, Yao C, Liu X.
    J Ethnopharmacol; 2012 Feb 15; 139(3):757-64. PubMed ID: 22178174
    [Abstract] [Full Text] [Related]

  • 6. The "Traditional Chinese medicine regulating liver regeneration" treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data.
    Dai L, Gao X, Ye Z, Li H, Yao X, Lu D, Wu N.
    Front Med; 2021 Jun 15; 15(3):495-505. PubMed ID: 33433899
    [Abstract] [Full Text] [Related]

  • 7. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH, Shi KQ, Dai ZJ, Ye C, Chen YP.
    Clin Ther; 2010 Apr 15; 32(4):649-58. PubMed ID: 20435234
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L, Chen H, Fan C, Gong Z.
    J Med Virol; 2013 Nov 15; 85(11):1907-12. PubMed ID: 23852947
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic efficacy and quality of life investigation of traditional Chinese medicine-based therapy of chronic hepatitis B-related liver fibrosis].
    An J, Ni W, Qiao J.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan 15; 22(1):30-2. PubMed ID: 24721240
    [Abstract] [Full Text] [Related]

  • 10. [The protective effect of Xuebijing injection pretreatment on hepatic ischemia reperfusion injury and coagulopathy after excision of liver cancer].
    Shen J, Lin XJ, Cui BK, Chi PD, Zeng QY, Zhao QY.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Dec 15; 25(12):743-8. PubMed ID: 24620386
    [Abstract] [Full Text] [Related]

  • 11. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
    Liu SY, Zhang YQ, Liu YL, Guo P, Zhou CM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov 15; 33(11):1457-61. PubMed ID: 24483103
    [Abstract] [Full Text] [Related]

  • 12. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J, Han JH, Liu C, Yu RH, Li FZ, Li QF, Gong GZ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun 15; 8(3):261-6. PubMed ID: 19502165
    [Abstract] [Full Text] [Related]

  • 13. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 15; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 14. [The short-term efficacy of antiviral treatment in patients with acute-on-chronic hepatitis B liver failure].
    Xu QH, Chen LB, Xu Z, Shu X, Chen N, Cao H, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec 15; 23(6):467-9. PubMed ID: 20718359
    [Abstract] [Full Text] [Related]

  • 15. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.
    Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, Zheng YB, Gao ZL.
    Hepatology; 2011 Sep 02; 54(3):820-8. PubMed ID: 21608000
    [Abstract] [Full Text] [Related]

  • 16. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X, Zhang B, Lu X, Yan M, Wen Y, Zhao T, Li P.
    BMC Complement Altern Med; 2016 Jul 26; 16():246. PubMed ID: 27460780
    [Abstract] [Full Text] [Related]

  • 17. [Impact and long-term effect of three prescriptions regulating and tonifying lung and kidney on JAK/STAT signaling in rats].
    Tian YG, Li Y, Li JS, Li SY, Jiang SL, Wang Y, Deng L, Wang YY.
    Zhongguo Zhong Yao Za Zhi; 2013 Jan 26; 38(1):75-80. PubMed ID: 23596881
    [Abstract] [Full Text] [Related]

  • 18. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study.
    Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL.
    Aliment Pharmacol Ther; 2006 Oct 15; 24(8):1179-86. PubMed ID: 17014576
    [Abstract] [Full Text] [Related]

  • 19. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
    Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, Huang XL.
    Zhong Yao Cai; 2006 Jul 15; 29(7):748-52. PubMed ID: 17059015
    [Abstract] [Full Text] [Related]

  • 20. [Protective effect of the use of Xuebijing injection during laparotomy on perioperative inflammatory response and organ function].
    Zhou X, Li H, Xie G, Fang J, Lian Y, Fang X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Apr 15; 26(4):258-63. PubMed ID: 24709499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.